Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin
- PMID: 11309273
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin
Abstract
Inappropriate activation of the Wnt/beta-catenin signaling, resulting mainly from activating mutations of the beta-catenin gene, has been implicated recently in the development of hepatocellular carcinoma (HCC). We have generated transgenic mice expressing an oncogenic form of beta-catenin in their hepatocytes to analyze the effect of deregulated beta-catenin signaling on liver homeostasis. These mice rapidly developed hepatomegaly soon after birth, with livers three to four times heavier than those of nontransgenic littermates. The liver cell hyperplasia resulted from increased cell proliferation without any compensatory apoptosis. Although the genes encoding c-myc and cyclin D1 are potential targets of the beta-catenin signaling pathway, neither of them was overexpressed in the hyperplastic livers of beta-catenin transgenic mice. Thus, the key target genes of the beta-catenin signaling pathway in the liver remain to be identified.
Similar articles
-
Role of beta-catenin in the adult liver.Hepatology. 2006 Apr;43(4):650-3. doi: 10.1002/hep.21154. Hepatology. 2006. PMID: 16557535 Free PMC article. Review. No abstract available.
-
Role of connexin32 and beta-catenin in tumor promotion in mouse liver.Toxicol Pathol. 2003 Jan-Feb;31(1):99-102. doi: 10.1080/01926230390173932. Toxicol Pathol. 2003. PMID: 12597453 Review.
-
Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.Cancer Res. 2002 Apr 1;62(7):1971-7. Cancer Res. 2002. PMID: 11929813
-
Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene.Oncogene. 2001 Sep 20;20(42):5972-81. doi: 10.1038/sj.onc.1204825. Oncogene. 2001. PMID: 11593404
-
Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.Cancer Res. 2001 Mar 1;61(5):2085-91. Cancer Res. 2001. PMID: 11280770
Cited by
-
Wnt/β-catenin signaling pathway in liver biology and tumorigenesis.In Vitro Cell Dev Biol Anim. 2024 May;60(5):466-481. doi: 10.1007/s11626-024-00858-7. Epub 2024 Feb 20. In Vitro Cell Dev Biol Anim. 2024. PMID: 38379098 Review.
-
New and Old Key Players in Liver Cancer.Int J Mol Sci. 2023 Dec 5;24(24):17152. doi: 10.3390/ijms242417152. Int J Mol Sci. 2023. PMID: 38138981 Free PMC article. Review.
-
β-Catenin signaling in hepatocellular carcinoma.J Clin Invest. 2022 Feb 15;132(4):e154515. doi: 10.1172/JCI154515. J Clin Invest. 2022. PMID: 35166233 Free PMC article. Review.
-
Transgenic zebrafish for modeling hepatocellular carcinoma.MedComm (2020). 2020 Sep 3;1(2):140-156. doi: 10.1002/mco2.29. eCollection 2020 Sep. MedComm (2020). 2020. PMID: 34766114 Free PMC article. Review.
-
Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma.Cancers (Basel). 2021 Aug 20;13(16):4202. doi: 10.3390/cancers13164202. Cancers (Basel). 2021. PMID: 34439356 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials